Hims & Hers Health Net Income 2020-2024 | HIMS

Hims & Hers Health annual/quarterly net income history and growth rate from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Hims & Hers Health net income for the quarter ending September 30, 2024 was $0.076B, a 1098.92% decline year-over-year.
  • Hims & Hers Health net income for the twelve months ending September 30, 2024 was $0.101B, a 383.65% decline year-over-year.
  • Hims & Hers Health annual net income for 2023 was $-0.024B, a 64.15% decline from 2022.
  • Hims & Hers Health annual net income for 2022 was $-0.066B, a 38.99% decline from 2021.
  • Hims & Hers Health annual net income for 2021 was $-0.108B, a 494.34% increase from 2020.
Hims & Hers Health Annual Net Income
(Millions of US $)
2023 $-24
2022 $-66
2021 $-108
2020 $-18
2019 $-72
2018 $
Hims & Hers Health Quarterly Net Income
(Millions of US $)
2024-09-30 $76
2024-06-30 $13
2024-03-31 $11
2023-12-31 $1
2023-09-30 $-8
2023-06-30 $-7
2023-03-31 $-10
2022-12-31 $-11
2022-09-30 $-19
2022-06-30 $-20
2022-03-31 $-16
2021-12-31 $-31
2021-09-30 $-16
2021-06-30 $-9
2021-03-31 $-51
2020-12-31 $-5
2020-09-30 $-6
2020-06-30 $-1
2020-03-31 $-6
2019-12-31
2019-09-30 $0
2019-06-30 $-0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.141B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00